Poster Presentation Australasian Society for Immunology Annual Scientific Meeting 2014

Thymic epithelial membrane antigen abundance dictates the routes available for MHCII-mediated central tolerance (#348)

Jin Yan Yap 1 , Debbie R Howard 1 , Christopher C Goodnow 1 2 , Stephen R Daley 1
  1. Department of Immunology, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia
  2. Australian Phenomics Facility, The Australian National University, Canberra, ACT, Australia
In the thymus, developing CD4+ T cells that bind strongly to self-antigen undergo clonal deletion or T-regulatory cell (Treg) differentiation to establish central self-tolerance. The contributions of epithelial versus haemopoietic thymic antigen-presenting cells (APCs) to these two mechanisms are unclear and may vary for self-antigens expressed in different cell types, in different subcellular locations or at different abundances. Central tolerance induction was compared in two lines of transgenic mice expressing the same Aire-dependent membrane-anchored self-antigen at either high or low levels in thymic epithelial cells. High- or low-level antigen induced thymocyte deletion at an early or late stage of T-cell development, respectively. For the high-level antigen, MHCII-deficiency on haemopoietic APCs caused deletion to occur later in T cell development and actually enhanced Treg differentiation. By contrast, MHCII-deficiency on haemopoietic APCs completely abolished central tolerance to low-level self-antigen. The findings show that highly expressed epithelial membrane-anchored self-antigen can induce central tolerance via antigen handover to haemopoietic APCs or via direct presentation by the epithelial cells themselves, whereas only the former mechanism is available when the same self-antigen is expressed at low levels. These data provide an explanation for clinical associations between low expression of membrane-anchored self-antigens and increased susceptibility to autoimmunity against these self-antigens.